Related Experiment Video
Updated: Apr 15, 2026
04:12
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
1.8K
Sebaceous hyperplasia: systemic treatment with isotretinoin.
Sandra Tagliolatto1, Octavio de Oliveira Santos Neto2, Maurício Mota de Avelar Alchorne3
1Campinas, Campinas, SP, Brazil.
Anais Brasileiros De Dermatologia
|April 2, 2015
Summary
Isotretinoin effectively treats sebaceous hyperplasia, significantly reducing lesions within two months. This therapeutic action was sustained long-term with minimal side effects, confirming its safety and efficacy.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Sebaceous hyperplasia presents as benign growths on the skin.
- Effective and safe treatment options for sebaceous hyperplasia are continuously sought.
Purpose of the Study:
- To evaluate the therapeutic efficacy of isotretinoin in treating sebaceous hyperplasia.
- To assess the long-term effects and safety profile of isotretinoin for this condition.
Main Methods:
- A two-month clinical study involving 20 patients with sebaceous hyperplasia.
- Patients received isotretinoin at 1mg/kg/day, with lesion counts and photographs taken before, after, and two years post-treatment.
Main Results:
- A significant reduction in average lesions from 24 to 2 per patient after two months (p < 0.05).
- Lesion count remained low at an average of 4 per patient two years after treatment cessation.
- No severe adverse events were reported during the study.
Conclusions:
- Isotretinoin demonstrates significant therapeutic action against sebaceous hyperplasia.
- The drug is confirmed as a safe and effective treatment option with sustained efficacy.
Related Concept Videos
01:27Acne Infection
72
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
72
01:21Accessory Structures of the Skin: Sebaceous Glands
5.8K
A sebaceous gland is a type of oil gland found almost all over the skin ( except palms and soles) and helps lubricate and waterproof the skin and hair. Most sebaceous glands are associated with hair follicles. They generate and excrete sebum, a mixture of lipids, onto the skin surface, thereby naturally lubricating the dry and dead layer of keratinized cells of the stratum corneum, keeping it pliable.
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
These glands that produce the oils on the skin and hair are holocrine glands. The mature...
5.8K
01:30Skin Cancer
6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
621
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
621
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
574
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
574